MGMT and glioblastoma: Nevertheless, RD demonstrated clinical significance in stratifying GBM patients into prognostic groups independent of MGMT methylation status, with the RD risk score serving as an independent prognostic factor more robust than initial Karnofsky Performance Status or the type of surgery performed [30,79,80,81].